Eli Lilly and Co. said Wednesday it will open four new U.S. manufacturing "mega sites" in the next five years, in a bid to reduce its reliance on overseas suppliers and take more control over its supply chain.
Why it matters: The "reshoring" comes amid the Trump administration's push to move more manufacturing inside U.S. borders and will create 3,000 jobs, as well as 10,000 construction jobs, Lilly said.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,